Event Insight

Does the UK Life Science and Technology Sector need the US?

May 29th 2025
An exclusive CXO Event hosted at the Royal Society of Medicine on Thursday 24th April 2025 by Frazier & Deeter, Newgrange Consultants and Compass Carter Osborne.

Key areas of discussion covered off:

  • Are potential tariffs, trade constraints and the political climate reasons to delay or cancel US market entry plans? 
  • For effective market entry, what are the most important first steps and plans to make as you establish and build your organisation?
  • How to you go about making your first employment decisions in the USA? 
  • What are the essentials for attracting US investors? 
  • How might your organisation evolve, and what should you seek to develop? 
Panellists:
  • Geoff Dobson (Discussion Chair), Newgrange Consultants 
  • Tarquin Bennett-Coles, Compass Carter Osborne
  • Laurie Spicer, Foothold America
  • Bradley Doline, Wilson Sonsini Goodrich & Rosati (UK), LLP
  • Malcolm Joy, Frazier & Deeter UK LLP
  • Will West, CellCentric
To obtain a copy of the full report and the responses to each question, download your copy below.

Tarquin Bennett-Coles, Director Compass Carter Osborne

Tarquin Bennett-Coles BEd (Hons)

Director

020 8036 3530
Geoff Dobson, Non-Executive Advisor Compass Carter Osborne

Geoff Dobson cFCIPD

Non-Executive Advisor

0208 036 3530